Home HOME Neoplasma 2022 Neoplasma Vol.69, No.1, p.233–241, 2022

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.69, No.1, p.233–241, 2022

Title: Prediction model based on 18F-FDG PET/CT radiomic features and clinical factors of EGFR mutations in lung adenocarcinoma
Author: Hong-Yue Zhao, Ye-Xin Su, Lin-Han Zhang, Peng Fu

Abstract: The aim of this study was to build a prediction model for epidermal growth factor receptor (EGFR) mutations in lung adenocarcinoma. A retrospective analysis was performed on 88 patients with lung adenocarcinoma. All patients underwent an 18F-FDG PET/CT scan and genetic testing of EGFR before the treatment. In the training set, the radiomics features and clinical factors were screened out, and model1 based on CT radiomics features, model2 based on PET radiomics features, model3 based on clinical factors, and model4 based on radiomics features combined with clinical factors were established, respectively. The performance of the prediction model was assessed by area under the receiver operating characteristic (ROC) curve (AUC). The DeLong test was used to compare the performance of the models to screen out the optimal model, and then built the nomogram of the optimal model. The effect and clinical utility of the nomogram was verified in the validation cohort. In our analysis, model4 was superior to the other prediction models in identifying EGFR mutations. The AUC was 0.864 (95% CI: 0.777-0.950), with a sensitivity of 0.714 and a specificity of 0.784. The nomogram of model4 was established. In the validation cohort, the concordance index (C-index) value of the calibration curve of the nomogram model was 0.841 (95% CI: 0.677-1.005), and the nomogram had a good clinical utility. We demonstrated that the model based on 18F-FDG PET/CT radiomics features combined with clinical factors could predict EGFR mutations in lung adenocarcinoma, which was expected to be an important supplement to molecular diagnosis.

Keywords: lung adenocarcinoma; radiomics; epidermal growth factor receptor; positron emission tomography/computed tomography
Published online: 15-Nov-2021
Year: 2022, Volume: 69, Issue: 1 Page From: 233, Page To: 241
doi:10.4149/neo_2021_201222N1388


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.